Picture of Cipher Pharmaceuticals logo

CPH — Cipher Pharmaceuticals News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareAdventurousSmall CapContrarian

Brief: Cipher Pharmaceuticals Receives Termination Notice From Bausch

Jan 20 (Reuters) - Cipher Pharmaceuticals Inc  CPH.TO :
    * CIPHER PHARMACEUTICALS RECEIVES NOTICE OF TERMINATION FROM
BAUSCH
    * CIPHER PHARMACEUTICALS -  RECEIVED NOTICE OF TERMINATION
FROM
BAUSCH HEALTH RELATED TO LICENSE, DEVELOPMENT &
COMMERCIALIZATION AGREEMENT OF TRULANCE
    * CIPHER PHARMACEUTICALS INC - NOTICE ALLEGES THAT CIPHER IS
IN
BREACH OF CERTAIN UNSPECIFIED PROVISIONS OF AGREEMENT
    * CIPHER PHARMACEUTICALS INC -  AS PART OF STRATEGIC REVIEW
PROCESS, CO WAS IN ACTIVE DISCUSSIONS TO SUB-LICENSE TRULANCE
WITH MULTIPLE PARTIES
    * CIPHER PHARMACEUTICALS INC - INTENDS TO CHALLENGE THE
NOTICE OF
TERMINATION

Source text for Eikon:  ID:nCNWK4GjLa 
Further company coverage:  CPH.TO 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Cipher Pharmaceuticals

See all news